01 June 2005 : Original article
Plasma transforming growth factor-b1 in acute viral hepatitis
Robert Flisiak, Danuta Prokopowicz, Jerzy Jaroszewicz, Iwona FlisiakMed Sci Monit 2005; 11(6): CR304-308 :: ID: 16510
Abstract
Summary
Background: TGFΒ[sub]1[/sub] has a confi rmed role in liver fi brosis and its antiproliferative, proapoptotic, and immunosuppressive
activities can play important roles in the pathogenesis of viral hepatitis.
Material/Methods: The concentrations of transforming growth factor-Β[sub]1[/sub] (TGFΒ[sub]1[/sub]) was measured with enzyme immunoassay in the plasma of 70 patients with acute viral hepatitis types A, B, and C to evaluate an association with the course and severity of the disease.
Results: The highest concentrations of TGFΒ[sub]1[/sub] were observed in the fi rst week of acute viral hepatitis types A and B (52.8±7.4 and 50.0±7.7, respectively). They were signifi cantly higher than normal values or levels in patients with hepatitis type C. Signifi cant correlation was observed between TGFΒ[sub]1[/sub] concentrations and alanine aminotransferase in all groups, whereas with aspartate aminotransferase only hepatitis A and B. A four-week follow-up showed a gradual decrease in TGFΒ[sub]1[/sub] levels in hepatitis A and B patients. In patients with acute C hepatitis, the relatively low initial TGFΒ[sub]1[/sub] concentrations increased in the second and third weeks of follow-up. Among HBV-infected patients the highest TGFΒ[sub]1[/sub] concentrations (75±17 ng/ml) were observed in the severe form of the disease.
Conclusions: These results support an important role of TGF-Β[sub]1[/sub] in the pathogenesis of acute viral hepatitis that seems to be connected with the degree of hepatocyte damage, but not with its mechanism or etiology.
Keywords: Hepatitis C - blood, Hepatitis, Viral, Human - blood, Biological Markers - blood, Hepatitis A - blood, Hepatitis B - blood, Hepatitis C - blood, Hepatitis, Viral, Human - blood, Hepatocytes - pathology, Reference Values, Transforming Growth Factor beta - metabolism, Transforming Growth Factor beta1
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
18 Mar 2024 : Clinical Research
Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative StudyMed Sci Monit In Press; DOI: 10.12659/MSM.944136
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
Most Viewed Current Articles
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952